Tuberculosis Diagnosed After Death in England: 574 Cases Over 12 Years
A study published this week found that 574 people in England received a tuberculosis diagnosis only after death between 2010 and 2022, averaging nearly one case per week. The findings, drawn from more than 72,000 TB notifications in UKHSA surveillance data, show that tuberculosis diagnosed after death in England is not a series of isolated failures but a pattern with a clear age distribution and a regional dimension. The study authors say each postmortem diagnosis should be treated as a patient-safety warning.
The research cannot establish whether TB caused or contributed directly to each death. That distinction matters. These 574 cases represent 0.8% of all TB diagnoses during the period, but they accounted for nearly one in five deaths recorded among people with TB, the authors wrote in The Conversation today. The core finding is not that TB killed people who would have survived with earlier treatment. It is that TB went undetected until autopsy, repeatedly, at a national scale, with no mandatory process to examine why.
What the study examined and what it showed
The national retrospective cohort study used routinely collected data from UKHSA's National TB Surveillance System, covering all TB notifications in England from January 2010 through December 2022. Of 72,058 people notified with TB, 19 without a recorded diagnostic outcome were excluded, leaving 72,039 for analysis, according to the study indexed by UKHSA. Of those, 574 were diagnosed postmortem, averaging 0.84 cases per week across the study period.
The study did not set out to prove that earlier diagnosis would have saved lives. It set out to identify which social and health factors were associated with postmortem diagnosis, and it found two consistent patterns: the likelihood rose sharply with age, and people outside London were more likely to receive a diagnosis after death than those in the capital. The authors describe postmortem diagnosis as the ultimate diagnostic delay, per the UKHSA research portal.
London's higher TB burden has historically supported more specialized clinical infrastructure and greater clinician familiarity with the disease. The study identifies the regional concentration but does not fully separate out its causes.
Why tuberculosis diagnosed after death in England still happens
Postmortem diagnosis is the far end of a delay problem that runs throughout England's TB diagnostic pathway. The median interval between symptom onset and a confirmed pulmonary TB diagnosis nationally was 72 days in 2024, the authors reported in The Conversation. Part of that gap is biological: TB bacteria grow slowly, and traditional laboratory cultures can take several weeks to return a result even when samples are collected promptly.
A separate problem appears in areas where TB is uncommon and clinicians encounter it rarely. In South West England, a low-incidence region, the total median delay from symptom onset to the start of treatment was 91.5 days between 2015 and 2020, and more than 30% of pulmonary TB patients waited longer than four months, according to a PLOS One study published earlier this year. Those researchers identified the delays as having direct consequences for transmission risk and illness severity. The South West finding is supporting context rather than proof that postmortem cases are most concentrated there; it shows that diagnostic delay is not confined to high-burden urban areas.
The broader national trend compounds the pressure. England's TB rate reached 9.4 per 100,000 in 2024, following the largest annual increase since 1971, placing England just below the WHO threshold that defines a low-incidence country, The Conversation reported. TB rates in England's most deprived communities are more than five times those in the least deprived areas, and in 2024 more than four in five people diagnosed with TB in England were born outside the UK. These patterns shape who carries the disease burden and who reaches diagnostic services in time, though the study does not attribute postmortem diagnoses to specific barriers faced by any single group.
What the researchers are calling for
The study authors make two concrete recommendations, neither of which currently reflects standard NHS practice.
First, every postmortem TB diagnosis should trigger a structured review of the clinical record, examining what symptoms were documented, which tests were ordered, and what referral decisions were made before the patient died, per the UKHSA study. That review does not happen automatically. Postmortem TB diagnoses can go unexamined at a system level, with no formal process to determine whether earlier detection was possible.
Second, the authors argue that postmortem TB diagnosis should be formally recognized as an NHS "never event," the classification reserved for a small number of incidents considered wholly preventable. That designation would require mandatory investigation and reporting each time one occurred, per the UKHSA portal. TB deaths do not currently meet that standard. Only 17% of those eligible for TB testing were actually tested in 2024, The Conversation reported, though the basis for eligibility determination is not detailed in the available evidence.
Both proposals are research advocacy, not adopted policy. The evidence does not directly prove that "never event" designation would reduce postmortem diagnoses; the argument is that mandatory accountability is a necessary precondition for improvement. No formal response from NHS England or UKHSA has been published in response to the study's recommendations.
What comes next
The twelve-year dataset covering more than 72,000 cases gives the findings weight that is hard to dismiss as statistical noise. The study authors argue that recognizing postmortem TB diagnosis as a "never event" and building targeted interventions to reduce diagnostic delays are essential if England is to meet its TB elimination goals, per the UKHSA publication.
The study cannot confirm how many of the 574 deaths were preventable. What it establishes is that a measurable, recurring failure to confirm TB before death continued across England for over a decade, concentrated in older patients and those outside the capital, without generating the mandatory review processes that other categories of serious patient-safety failures require.
The immediate question is whether NHS England, UKHSA, or the Department of Health and Social Care respond to the two specific recommendations. Readers tracking England's TB response should watch for formal guidance on case review requirements and any movement toward reclassifying postmortem TB diagnosis within the NHS never events framework, particularly as rising national incidence rates add further pressure to a system already managing the largest annual case increase in more than fifty years.